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ABSTRACT 
Five compounds, {(μ-OAc)(DPPD)Cd(μ-PYZ)Cd(DPPD)(μ-OAc)}n (1); HDPPD: 1,3-
diphenylpropane-1,3-dione; PYZ: pyrazine, {Cd(μ-4,4'-Bipy)(DPPD)2}n (2) Bipy: bipyridine 
[(DPPD)2Zn(μ-4,4'-Bipy)Zn(DPPD)2] (3), {Cd(μ-DPP)(DPPD)2}n (4); DPP: 1,3-di(pyridin-4-
yl)propane and (Z)-3-hydroxy-1,3-bis(4-methoxyphenyl)prop-2-en-1-one (Z-HMPP), were 
prepared and identified by elemental analysis, FT-IR, 
1
H NMR spectroscopy and single-
crystal X-ray diffraction.  1,2 and 4 form 1D coordination polymers whereas 3 adopts a 
binuclear structure with the zinc atom in a distorted square-pyramidal geometry. In addition 
to these complexes, the enolic structure of the Z-HMPP is reported. The ability of compounds 
to interact with the nine biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, 
rHA, RNR, TrxR, TS and Top II) is investigated by the Docking calculations (for 3 and its 
ligands). The charge distribution pattern of the optimized structure of 3 was studied by NBO 
analysis. The Polymer Stability Slope for pentameric chain (PSS
5
, new parameter which is 
proposed in this paper) of the coordination polymers of 1, 2 and 4 were calculated to 
investigate the variation of energy level during the growing the polymeric chain in the solid 
phase. 
Keywords: Cadmium(II); Nitrogen donor linker; DFT study; Docking study; Coordination 
polymer 
1. Introduction 
Coordination polymers are interesting metal-organic hybrid materials in which metal ions or 
metal-containing clusters act as nodes and organic ligands act as spacers; both units are 
linked via coordination bonds to form one-, two- or three-dimensional extended structures 
[1]. This class of compounds has been used as electrodes in supercapacitors [2], gas 
storage/separation and ion exchange [3-8],  biological and material science [9, 10], sensing 
  
3 
 
[11-15], precursors for the preparation of nano-materials [16], magnetism [17-21], 
luminescent materials nonlinear optics [22-25], catalysis [26-29],. 
 Aromatic β-diketones are frequently used as chelating ligands for Lewis acids and to 
produce complexes used in many applications such as catalysis [30], vapour deposition [31], 
luminescent compounds [32, 33], near infrared organic light emitting devices [34, 35] and 
optoelectronics [36]. For example, difluoroboron diketonates [37] have lately received 
tremendous attention due to their mechanochromic luminescence (ML) [38] and room-
temperature phosphorescence properties [39-41]. Some 1D-, 2D- and 3D-coordination 
polymers containing β-diketone derivatives have been reported [42, 43].  
 In order to extend the chemistry of these coordination polymers, in this work, the 
synthesis of compounds including, {(μ-OAc)(DPPD)Cd(μ-PYZ)Cd(DPPD)(μ-OAc)}n (1); 
HDPPD: 1,3-diphenylpropane-1,3-dione (Scheme 1); PYZ: pyrazine (Scheme 1), {Cd(μ-4,4'-
Bipy)(DPPD)2}n (2); Bipy: bipyridine (Scheme 1), [(DPPD)2Zn(μ-4,4'-Bipy)Zn(DPPD)2] (3), 
{Cd(μ-DPP)(DPPD)2}n (4); DPP: 1,3-di(pyridin-4-yl)propane (Scheme 1) and (Z)-3-hydroxy-
1,3-bis(4-methoxyphenyl)prop-2-en-1-one (Z-HMPP), are described, along with the 
characterization and theoretical study of the compounds. 
 In addition to the expected biological properties of compounds containing β-diketons 
[44, 45] and pyridine derivatives [46-49], binding of the zinc(II) ion to this unit make these 
complexes as a good choice for biologically active compounds [50-52], thus docking 
calculations were run to investigate the possibility of interaction between 3 and its ligands 
(4,4'-bipyridine and DPPD) with the nine protein targets, including: BRAF kinase, Cathepsin 
B (CatB), DNA gyrase, Histone deacetylase (HDAC7), recombinant Human albumin (rHA), 
Ribonucleotide reductases (RNR), Thioredoxin reductase (TrxR), Thymidylate synthase 
(TS), Topoisomerase II (Top II). These proteins are used in this project either due to their 
reported roles in the cancer growth or as transport agents that affect drug pharmacokinetic 
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properties (e.g., rHA). Also, DNA gyrase was included to study the possibility of the 
compounds also acting as antimalarial agents [53]. 
2. Experimental 
2.1 Materials and Instrumentation  
All starting chemicals and solvents were reagent or analytical grade and used as received. 
Infrared spectra in the range 4000–400 cm–1 were recorded on KBr pellets with a FT-IR 
8400-Shimadzu spectrometer. 
1
H NMR spectra were recorded on a Bruker spectrometer at 
250 MHz; chemical shifts δ are given in parts per million, relative to TMS as an internal 
standard. The carbon, hydrogen and nitrogen contents were determined in a Thermo Finnigan 
Flash Elemental Analyzer 1112 EA. Melting points were determined with a Barnsted 
Electrothermal 9200 electrically heated apparatus. 
2.1.1 Synthesis of {(μ-OAc)(DPPD)Cd(μ-PYZ)Cd(DPPD)(μ-OAc)}n (1) 
HDPPD (0.135 g, 0.6 mmol), pyrazine (0.072 g, 0.9 mmol) and Cd(OAc)2·2H2O (0.080 g, 
0.3 mmol) were placed in the large arms of a branched tube (see ref [54]). Ethanol was 
carefully added to fill both arms. The tube was then sealed and the ligand-containing arm was 
immersed in a bath at 60 C while the other arm was maintained at ambient temperature [55]. 
After a few days, the colorless crystals deposited in the cooler arm were filtered off and dried 
in air. Yield: 0.058 g, 45%; m. p. 212−217 °C. Anal. Calcd for C19H16CdNO4 (434.73): C, 
52.49; H, 3.71; N, 3.22. Found: C, 52.62; H, 3.75; N, 3.19%. IR (KBr, cm
−1
): 3105 w (ν 
CH)
ar
, 3063 w (ν CH)β-diketone, 2997 w (ν CH), 1592 s (ν C=C + ν C=O)β-diketone, 1580 m (ν 
C=N), 1543 m (νas COO)
OAc
, 1522 m (ν C=O + ν C=C), 1456 w (ν C=Car and/or δas CH3), 
1434 m (νs COO
Oac
 and/or δ CH + ν C=Cβ-diketone), 1343 w (δs CH2), 674 (δ OCO)
OAc
. 
1
H 
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NMR (250 MHz, DMSO-d6, ppm, Hz): δ= 8.64 )s, 2 H, pyrazine), 7.40−7.91 )m, 10 H, 
phenyl-DPPD), 6.54 )s, 1 H, β-diketone), 1.82 )s, 3H, OAc). 
2.1.2 Synthesis of {Cd(μ-4,4'-Bipy)(DPPD)2}n (2) 
The procedure for synthesis of 2 was similar to 1 except that pyrazine was replaced by 4,4'-
bipyridine (0.141 g, 0.9 mmol) using the MeOH/H2O in a ratio of 3:1. Yield: 0.028 g, 13%; 
m. p. 204−214 °C. Anal. Calcd for C40H30CdN2O4 (715.06): C, 67.18; H, 4.23; N, 3.92. 
Found: C, 67.32; H, 4.28; N, 4.01%. IR (KBr, cm
−1
): 3091 w (ν CH)ar, 3056 w (ν CH)β-diketone, 
1597 s (ν C=C + ν C=O)β-diketone, 1552 m (ν C=O + ν C=C)β-diketone, 1513 m (ν C=N), 1477 m 
(ν C=C)ar, 1454 s (δ CH + ν C=C)β-diketone. 1H NMR (250 MHz, DMSO-d6, ppm, Hz): δ= 
8.69−8.71 )d, 4 H, 4,4'-bipy), 7.90−8.17 )m, 8 H, DPPD), 7.79−7.81 )d, 4 H, 4,4'-bipy), 
7.33−7.66 )m, 12 H, DPPD), 6.54 )s, 2 H, β-diketone). 
2.1.3 Synthesis of [(DPPD)2Zn(μ-4,4'-Bipy)Zn(DPPD)2] (3)  
The procedure for synthesis of 3 was similar to 2 except that Cd(OAc)2·2H2O was replaced 
by Zn(OAc)2·2H2O (0.066 g, 0.3 mmol) using the MeOH/EtOH in a ratio of 3:1. Yellowish 
crystals were formed after a few days in the cooler arm and filtered. Yield: 0.026 g, 15%; m. 
p. 237−238 °C. Anal. Calcd for C70H52N2O8Zn2 (1179.87): C, 71.25; H, 4.44; N, 2.37. Found: 
C, 71.51; H, 4.53; N, 2.35%. IR (KBr, cm
−1
): 3102 w (ν CH)ar, 3066 w (ν CH)β-diketone, 1606 
m (ν C=C + ν C=O)β-diketone, 1555 m (ν C=O + ν C=C)β-diketone, 1544 m (ν C=N), 1474 s (ν 
C=C)
ar
, 1458 s (δ CH + ν C=C)β-diketone. 1H NMR (250 MHz, DMSO-d6, ppm, Hz): δ= 8.73 
)d, 2 H, 4,4'-bipy), 8.02−8.05 )d, 8 H, DPPD), 7.80−7.82 )d, 2 H, 4,4'-bipy), 7.46−7.48 )m, 12 
H, DPPD), 6.76 )s, 2 H, β-diketone).  
2.1.4 Synthesis of {Cd(μ-DPP)(DPPD)2}n (4) 
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The procedure for synthesis of 4 was similar to 1 except that pyrazine was replaced by DPP 
(0.178 g, 0.9 mmol) using the MeOH/EtOH in a ratio of 1:3. After one week, the reaction 
mixture was filtered and then colorless crystals suitable for X-ray diffraction studies were 
obtained by slow evaporation after a few days. Yield: 0.017 g, 8%; m. p. 215 °C. Anal. Calcd 
for C43H36CdN2O4 (757.14): C, 68.21; H, 4.79; N, 3.70. Found: C, 67.94; H, 4.77; N, 3.71%. 
IR (KBr, cm
−1
): 3087 w (ν CH)ar, 3060 w (ν CH)β-diketone, 2945 w (ν CH2), 1594 s (ν C=C + ν 
C=O)
β-diketone
, 1547 m (ν C=O + ν C=C)β-diketone, 1515 m (ν C=N), 1478 m (ν C=C)ar, 1455 s (δ 
CH + ν C=C)β-diketone, 1406 s (δas CH2), 1301 w (δs CH2). 
1
H NMR (250 MHz, DMSO-d6, 
ppm, Hz): δ= 8.43−8.45 )d, 4 H, DPP), 7.89−7.91 )d, 8 H, DPPD), 7.41 )m, 12 H, DPPD), 
7.22−7.24 )m, 4 H, DPP), 6.53 )s, 2 H, β-diketone), 2.56−2.63 (t, 4 H, DPP), 1.87−1.93 (m, 2 
H, DPP).   
  
2.1.5 Preperation of (Z)-3-hydroxy-1,3-bis(4-methoxyphenyl)prop-2-en-1-one (Z-
HMPP) 
The procedure for synthesis of Z-HMPP was similar to 3 except that HDPPD and pyrazine 
was replaced by 1,3-bis(4-methoxyphenyl)propane-1,3-dione, HMPP (0.171 g, 0.6 mmol), 
and 1,2-di(pyridin-4-yl)ethane, DPE (0.164 g, 0.9 mmol), using the MeOH. After a few days, 
yellow crystals that were deposited in the cooler arm were filtered off and dried in air. Yield: 
0.050 g; m. p. 222 °C. Anal. Calcd for C17H16O4 (284.30): C, 71.82; H, 5.67. Found: C, 
71.96; H, 5.66%. IR (KBr, cm
−1
): 3060 w (ν CH)ar, 2962 w (ν CH3), 1604 s (ν C=O)
enol
, 1545 
w (ν C=C)enol, 1491 m and 1458 w (ν C=C)ar, 1438 m (δas CH3), 1303 m (ν C−O
enol
 and/or δs 
CH3). 
1
H NMR (250 MHz, DMSO-d6, ppm, Hz): δ= 8.10−8.13 )d, 4 H, Ph), 7.51 )s, 1 H, β-
diketone), 7.17 )s, 1 H, OH), 7.05−7.08 )d, 4 H, Ph), 3.82−3.84 (s, 6 H, methoxy).     
2.2 Crystal structure determination  
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Suitable crystals of 1−4 and Z-HMPP were chosen and their X-ray analysis were done using 
Apex-II Duo CCDC diffractometer with fine-focus sealed tube graphite-monochromated Mo-
Kα radiation (λ = 0.71073 Å) at room temperature. The data was processed with SAINT and 
corrected for absorption using SADABS [56]. The structures were solved by direct method 
using the program SHELXTL [57] and were refined by full-matrix least squares technique on 
F
2
 using anisotropic displacement parameters for all non-hydrogen atoms. Diagrams of the 
molecular structure and unit cell were created using Ortep-III [58, 59] and Diamond [60] 
softwares. Details of crystal data, data collection, structure solutions and refinements are 
given in Table 1. Selected bond lengths and angles of complexes are listed in Table 2 and 
hydrogen bond geometries in Table S2 (Supplementary Materials). 
2.3 Computational details 
All structures were optimized with the Gaussian 09 software [61] and calculated for an 
isolated molecule using Density Functional Theory (DFT) [62] at the B3LYP/LanL2DZ level 
of theory for complex 3 as well as for NBO analysis and B3LYP/6-31+G for Z-HMPP and 
HDPPD isomers. Cif files of complex 3 and Z-HMPP were used as input file for theoretical 
calculations.  
2.4 Docking details 
The pdb files 4r5y, 3ai8, 5cdn, 3c0z, 2bx8, 1peo, 3qfa, 1njb, 4gfh for the nine receptors, 
BRAF kinase, Cathepsin B (CatB), DNA gyrase, Histone deacetylase (HDAC7), recombinant 
Human albumin (rHA), Ribonucleotide reductases (RNR), Thioredoxin reductase (TrxR), 
Thymidylate synthase (TS), Topoisomerase II (Top II), respectively, used in this research 
were obtained from the Protein Data Bank (pdb) [59]. The obtained full version of Genetic 
Optimisation for Ligand Docking (GOLD) 5.5 [63] was used for the docking. The Hermes 
visualizer in the GOLD Suite was used to further prepare the metal complexes and the 
  
8 
 
receptors for docking. The optimized DPPD and 4,4'-bipyridine ligands and also cif file of 
the complex 3 were used for docking studies. The region of interest used for Gold docking 
was defined as all the protein residues within the 6 Å of the reference ligand “A” that 
accompanied the downloaded protein. All free water molecules in the structure of the proteins 
were deleted before docking. Default values of all other parameters were used and the 
complexes were submitted to 10 genetic algorithm runs using the GOLDScore fitness 
function. 
3. Results and Discussion 
Reaction between cadmium(II) acetate with HDPPD/pyrazine, HDPPD/4,4'-bipyridine and 
HDPPD/DPP mixtures in branched tubes provide 1D coordination polymers 1, 2 and 4, 
respectively. In similar reaction, the zinc(II) acetate was reacted with HDPPD/4,4'-bipyridine 
mixture and observed that the zinc atom preferred a binuclear structure respect to the 
polymeric backbone. The complexes are air-stable and soluble in DMSO. 
3.1 Spectroscopic characterization 
In the IR spectra of the complexes 1−4, the relatively weak absorption bands at about 3100 
and 3050 cm
–1
 are due to the C–H modes of the aromatic rings and β-diketone unit, 
respectively. For complexes 1 and 4, frequencies near the 2950 cm
–1
 are related to the 
aliphatic moieties (acetate in 1 and propane in 4) in their structures. In all the spectra of 
complexes, there are three bands corresponding to the anionic β-diketone unit of the DPPD 
including 1550−1600 cm–1 due to the ν (C=C) coupled with ν (C=O), 1500−1550 to the ν 
(C=O) coupled with ν (C=C) and near 1450 cm–1 to the δ (C−H) coupled with ν (C=C) [64]. 
The neutral free HDPPD has a band 1655 cm
–1
 corresponding to the carbonyl unit of the keto 
form [65] which is shifted to lower frequencies upon coordination due to the deprotonation of 
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the β-diketone unit. The pyridine and pyrazine rings of the linkage ligands are noted in the 
FT-IR spectra of complexes in the region of 1500−1600 cm−1 owing to the ν (C=N)ar [66].    
 In the FT-IR spectrum of 1, three bands at 1543, 1434 and 674 cm
–1
 were assigned to 
the νas (COO), νs (COO) and δ (OCO) respectively [67], confirming the presence of the 
acetate unit in this complex. The differences between asymmetric (νas) and symmetric (νs) 
stretching of the acetate group (∆) can reveal its coordination type. In monodentate
complexes, ∆ values are much greater than the acetate salt (164 cm–1) while in bidentate 
complexes these values are significantly less than the acetate salt [68, 69]. The ∆ value for 1 
is 109 cm
–1
 which is corresponding to the bidentate acetate ligand.   
 The 
1
H NMR spectrum of the complex 1 (Supplementary Materials) revealed that 
aromatic (7.40−8.64 ppm), aliphatic (1.82) and alkene (6.54 ppm) moieties of this structure. 
The hydrogen atoms of the acetato and pyrazine ligands are observed at the highest and 
lowest magnetic field, respectively. A singlet at the 6.54 ppm with integral of 1 is 
characteristic peak of the anionic β-diketone unit of the DPPD. By comparing the intensity of 
this signal with acetato and pyrazine ligands, the structure of the complex can be determined. 
Based on the intensity ratio of 3:1:2 respectively for acetate, β-diketone unit and pyrazine 
ligand, we can conclude that the stoicometery of 1 mol acetate,1 mol DPPD and 0.5 mol 
pyrazine per each cadmium atom in the structure of the complex 1 which is confirmed by the 
X-ray analysis.  
 The 
1
H NMR spectrum of 2 revealed that a mixed ligands structure. The sum of the 
integral numbers of all signals related to the DPPD is 22 (each DPPD has 11 hydrogen atoms) 
and 4,4'-bipyridine is 8 (each 4,4'-bipyridine has 8 hydrogen atoms), confirming the 
stoicometery of 2:1 for DPPD:4,4'-bipy. Two doublet signals for 4,4'-bipyridine ligand reveal 
a symmetrical bridging coordination mode. The integral numbers in the 
1
H NMR spectrum of 
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3 supports a different stoicometery to 2. In this complex, the stoicometery of DPPD:4,4'-bipy 
is 2:0.5 which can be adopt only with the binuclear structure in which the 4,4'- bipyridine 
coordinates as symmetrical bridged ligand between two zinc atoms. 
 In the 
1
H NMR spectrum of the complex 4, eight hydrogen atoms of the two pyridinic 
rings of the DPP ligand appear as two sets of dublet signals which support the symmetrical 
bridging behaviour of this ligand. Also sum of the integral numbers of the DPPD and DPP 
ligands confirms the ratio of 2:1, respectively, thus a polymeric structure is anticipated for the 
complex 4.  
    The FT-IR and 
1
H NMR spectra of Z-HMPP reveal a β-diketone ligand in its enolic 
form. In the FT-IR spectrum of this compound, the frequencies at 1604, 1545 and 1303 cm
–1 
correspond to the ν (C=C), ν (C=O) and ν (C−O) which are characteristics of the enolic form 
[70]. Also singlet signals of the 7.51 and 7.17 ppm in the 
1
H NMR spectrum were assigned to 
the hydrogen atoms methylene and alcoholic groups of the β-diketone moiety in agree with 
its enolic structure.      
3.2 Description of the crystal structures  
3.2.1 Crystal structures of {(μ-OAc)(DPPD)Cd(μ-PYZ)Cd(DPPD)(μ-OAc)}n (1) 
In the crystal structure of 1  (Fig. 1), the cadmium atom is coordinated by three oxygen atoms 
of two acetato ligands, two oxygen atoms of one DPPD and one nitrogen atom of a pyrazine 
ligand with distorted octahedral geometry. Among the five Cd–O bond lengths, the bond 
lengths of DPPD ligand are shorter than the others. The complex has one center of inversion 
on the center of pyrazine ring and Ci symmetry. This structure is a 1D asymmetric zigzag-
coordination polymer (Figures S1, S5, Supplementary Materials) [71] of cadmium containing 
two types of bridges, one Cd-pyrazine-Cd bridge and two Cd-acetato-Cd bridges. The DPPD 
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ligand does not participate in the polymeric backbone but completes the octahedral geometry 
around the cadmium atom (Fig. S5, Supplementary Materials). To compare the coordination 
mode of the acetato ligand in 1 with published analogues, a structural survey was carried out 
and results are presented in Table S3 (Supplementary Materials). These data revealed that 
seven different coordination modes have been reported for cadmium complexes containing 
the acetato ligand. Among these coordination modes, the “(O,O)” mode (Fig. 2) is the most 
observed ones (54%) in which the acetato unit acts as O2-donor and forms one four-
membered chelate ring. The observed mode in 1 is “(O,μ-O)” which is the second most 
common in the CSD analogues (24%). In another comparison, the percentage of bridged and 
non-bridged structures was calculated. These data revealed that the acetato unit commonly 
forms a non-bridged structure (71%). In mostly cases this ligand forms a chelate ring with 
cadmium atom (81%).   
Each DPPD ligand acts as bidentate and forms a six-membered planar chelate ring 
(with r.m.s value of 0.075 Å for O1 atom). Two phenyl groups are not coplanar with the 
chelate ring and are bended from this plane with the average bending angles of 39.07°. For 
study of the bond lengths and angles variation of the HDPPD after coordination to the 
cadmium atom, the geometrical parameters of free ligand (Scheme S2, Supplementary 
Materials) [72] were compared with the 1. After coordination, the C−C−C bond angle of the 
β-diketone moiety (127.20°) is increased about 6.78° and the bending angle of the phenyl 
groups respect to the plane through the β-diketone moiety (39.07°) is increased about 28.2° 
(these values for free ligand are 120.42° and 10.86°, respectively).      
The pyrazine ligand in the complex of 1 connects two cadmium atoms. These atoms 
are not lie on the mean plane through the pyrazine ring; one cadmium atom places above this 
plane and another under it with distance of 0.229 Å.  
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3.2.2 Crystal structure of {Cd(μ-4,4'-Bipy)(DPPD)2}n (2) 
In the crystal structure of 2 (Fig. 3), the cadmium atom is coordinated by two O-donor DPPD 
and two 4,4'-bipyridine with slightly distorted octahedral geometry (Fig. S6, Supplementary 
Materials). The 4,4'-bipyridine ligand connects two cadmium atoms to form 1D linear-
coordination polymer [71]. The Cd−O bond lengths are shorter than the Cd−N bond lengths 
(Table 2) and these two bond lengths are comparable with the CSD average for complexes 
containing the unit (Scheme S3 (a), Supplementary Materials). 
In this structure, the six-membered chelate ring formed by DPPD is not planar (with 
r.m.s value of 0.265 Å for O2 atom). The average of bending angles of two phenyl groups 
from the chelate ring is 41.85° which is higher than that of the complex 1. These observations 
(non-planar chelate ring and increasing the bending angle of phenyl groups) can be attributed 
to the increasing the C−C−C bond angle of the β-diketone moiety about 0.73° respect to the 
1.  
The two pyridine rings of the 4,4'-bipyridine ligand are not coplanar and dihedral angle 
between their planes is 41.39° which is higher than the CSD average for bridged 4,4'-
bipyridine between two cadmium atom (17.07°). This angle in the free ligand [73] is 26.69° 
(this value is the average of dihedral angles for two independent structures [73]).   
3.2.3 Crystal structure of [(DPPD)2Zn(μ-4,4'-Bipy)Zn(DPPD)2] (3) 
In the crystal structure of the complex 3 (Fig. 4), there are two independent binuclear zinc 
complexes with slightly difference in geometrical parameters. The zinc atom is coordinated 
by one nitrogen atom of a 4,4'-bipyridine ligand and four oxygen atoms of two DPPD ligand 
with coordination number of five. A penta-coordinate geometry of 3, may adopt either a 
square pyramidal or a trigonal bipyramidal structure which is determined by applying the 
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formula of Addison et al. [74, 75]. The angular structural parameter, τ (τ = (β – α)/60, where 
α and β are the two largest angles at the zinc atom with β ≥ α), was calculated to be 0.31 and 
0.30, respectively for Zn1A and Zn1B indicating a distorted square-pyramidal geometry (Fig. 
S7, Supplementary Materials). Studying the CSD database for the base presented in Scheme 
S3 (b), Supplementary Materials, revealed that the coordinated bond lengths of 3 are 
comparable with the CSD average (Zn−N, 2.057; Zn−O, 2.006) and in all complexes the 
average of all Zn−O bond lengths is shorter than the Zn−N bond lengths.  
 The coordinated DPPD ligand forms a non-planar six-membered chelate ring around the 
zinc atom. The average of dihedral angles between phenyl groups and chelate ring plane is 
14.57° which is lower than in1 and 2 which can be related to the lowest value of the C−C−C 
bond angle in 3 (126.00°) respect to the 1 and 2.  
 The dihedral angle between two pyridine rings of the 4,4'-bipyridine ligand is 0.00°, 
showing that the planar coordination behavior of this ligand toward zinc atom. This value for 
the CSD analogues is 14.94° which is lower than that of the cadmium analogues (17.07°).   
3.2.4 Crystal structure of {Cd(μ-DPP)(DPPD)2}n (4) 
X-ray analysis of the complex 4 reveals (Fig. 5) 1D symmetric linear-coordination polymer; 
extending by bridging 1,3-di(pyridin-4-yl)propane between cadmium atoms. In this structure, 
the cadmium atom by coordination of four oxygen atoms of two O2-donor DPPD and two 
nitrogen atoms of two 1,3-di(pyridin-4-yl)propane has a octahedral geometry (Fig. S8, 
Supplementary Materials). The Cd−O bond lengths (2.241 Å) are shorter than the Cd−N 
(2.370 Å) and theses two bond lengths are comparable with the CSD average (Scheme S3 (a), 
Supplementary Materials). 
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The dihedral angles average between phenyl groups with the planar chelate ring of 
DPPD (with r.m.s value of 0.029 Å for C7 atom) is 19.89° which is higher than that of the 
free ligand and can be attributed to the increasing the C−C−C bond angle of coordinated 
DPPD (Table 3). The dihedral angle between two pyridine rings of the 1,3-di(pyridin-4-
yl)propane ligand is 79.87°.   
3.2.5 Crystal structure of (Z)-3-hydroxy-1,3-bis(4-methoxyphenyl)prop-2-en-1-one (Z-
HMPP) 
X-ray analysis of the (Z)-3-hydroxy-1,3-bis(4-methoxyphenyl)prop-2-en-1-one revealed a Z 
conformation and enolic form of this ligand (Fig. 6). These types of the compounds have two 
tautomeric forms including enol and keto. Study of the all CSD structures containing β-
diketone unit (the structures in which the β-diketone unit is fused to a ring were omitted) 
revealed that the enol form (292 hits, 88%) is more common than the keto form (41 hits, 
12%) as observed in the Z-HMPP. The bond lengths average of the β-diketone unit were 
extracted and presented in Scheme S4, Supplementary Materials. The data revealed that the 
C=O bond length is the shortest bond in this unit. The hydrogen atom of the hydroxyl group 
along with the oxygen atom of the side carbonyl group form a planar six-membered hydrogen 
bonding ring (with r.m.s value of 0.039 Å for H1 atom). The phenyl groups of the ligand are 
almost coplanar with this ring with the dihedral angle average of 3.87°. 
3.2.6 Crystal network interactions 
In the crystal network of compounds (Figures S5, S6, S7, S8, S9, Supplementary Materials) 
intermolecular C–H···O, and C–H···C (except in 1 and Z-HMPP) also intramolecular O–
H···O (Z-HMPP) hydrogen bonds appear between adjacent complexes. In this way the 
carbon and oxygen atoms participate in hydrogen bonding as proton donors and acceptors at 
the same time. In addition to the hydrogen bonds, the crystal networks of the compounds are 
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further stabilized by π–π stacking interactions between aromatic rings [76, 77] of the adjacent 
ligands (Figures S5, S6, S7, S8, S9, Supplementary Materials). In the crystal network of 1 
(Fig. S5, Supplementary Materials), there are π–π stacking interaction between the pyrazine 
and phenyl group of the DPPD which has the shortest centroid–centroid distance among the 
all compounds and strongest ones (Table S1, Supplementary Materials). Similar interaction is 
appeared between phenyl ring of the DPPD and pyridine ring of the 4,4'-bipyridine ligands. 
Although the complexes 2 and 3 have similar ligands but have different π–π stacking pattern 
(Figures S6, S7, Supplementary Materials). In this pattern, in addition of π–π stacking 
interaction between two 4,4'-bipyridine ligands, two DPPD ligands which are not exactly on 
top of each other, form two different types of interactions including Ph∙∙∙β-diketone and 
Ph∙∙∙Ph (Table S1, Supplementary Materials). The centroid–centroid distance of the Ph∙∙∙β-
diketone stacking is shorter than the Ph∙∙∙Ph and thus is stronger than it. In the crystal network 
of 4 (Fig. S8, Supplementary Materials), the pyridine rings of the DPP ligand do not 
participate in the π–π stacking interactions while phenyl and β-diketone units of the DPPD 
have important role in this way.   
 Total intermolecular interaction energy
1
 for one molecule of complex 3 and Z-HMPP 
were calculated using Mercury [78] and its CSD-materials tool [79, 80]. For this, the sum of 
the intermolecular interactions energy in a molecular packing shell containing 100 molecules 
[81] around the one molecule of 3 and Z-HMPP were calculated to be −997.12 (complex 3 
containing Zn1B), −969.762 (complex 3 containing Zn1A) and –339.548 kJ/mol (Fig. 7), 
respectively, confirming that one molecule of complex 3 is more stabilized in the solid state 
by its network interactions than Z-HMPP [81]. Also the interactions of the enantiomer 
containing Zn1B, in complex 3, are stronger than its Zn1A enantiomer. In complex 3, 50% 
(Zn1B enantiomer) and 52% (Zn1A enantiomer) of the total energy is corresponding to the 
                                                             
1 This parameter can be calculated only for non-polymeric structures 
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interactions with its four closest neighboring molecules in ranges of 5.401−10.802 Å 
distances (Fig. 7). This value for the same condition in Z-HMPP is 61% within the distances 
range of 4.186−7.992 Å.  
3.3 Theoretical studies  
For investigation the variation of energy level with growing the polymeric chain in the solid 
phase (without considering the intermolecular interactions) in complexes 1, 2 and 4, a DFT 
calculation was performed and results are presented in Fig. 8. For this aim, a monomeric 
species as a core ([Cd2(μ-OAc)2(PYZ)2(DPPD)2], [Cd(4,4'-Bipy)2(DPPD)2], 
[Cd(DPP)2(DPPD)2], respectively for 1, 2 and 4) was extracted from the corresponding cif 
and then the energy variations were studied upon growing the chain by adding the monomers 
of [Cd2(μ-OAc)2(PYZ)(DPPD)2], [Cd(4,4'-Bipy)(DPPD)2] and [Cd(DPP)(DPPD)2], 
respectively for 1, 2 and 4, to form a pentameric structure. With increasing the chain length 
the total energy for all complexes is increased but with different slopes. The Polymer 
Stability Slope for pentameric chain (PSS
5
, new parameter which is proposed in this paper) 
for three complexes has the general trend 1 > 4 > 2 (−2274, −2118 and −2000, respectively 
for 1, 2 and 4), showing that the rate of increasing the thermodynamic stability in 1 is higher 
than the others. It seems that the bridging ligands have significant effect on the PSS
5 
index of 
the complexes (DPPD ligand is same in three complexes).  
 To study the charge distribution before and after complexation, an NBO analysis was 
done on the free 4,4'-bipyridine, anionic DPPD and complex 3
opt
 (Table S4, Supplementary 
Materials). For this study two free ligands and their complex with zinc (3
opt
) were optimized 
before NBO analysis. The results reveal that the calculated charge on the zinc atom is about 
+1.41 and lower than the formal charge (+2) owing to the electron donation of ligand during 
the complexation. Based on the calculated total charge values, the charge of the carbon and 
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hydrogen atoms belonging to the coordinated 4,4'-bipyridine and DPPD are more positive 
than that of the free ligands, whilst the total charge of nitrogen (coordinated 4,4'-bipyridine) 
and oxygen (coordinated DPPD) atoms is more negative than respect to the free 4,4'-
bipyridine and DPPD ligands. This observation reveals that the hydrogen and carbon atoms 
play an important role in electron donation toward metal atom, thus decreasing the charge of 
the zinc atom.   
 In the binuclear complex 3
opt
, the zinc atom has a trigonal bipyramidal geometry (τ = 
0.97) while in the solid state phase the coordinated ligands create a distorted square-
pyramidal geometry around the zinc atom to enable the best direction to interact with 
adjacent complexes. Similarly to the solid phase, all Zn−O (with average of 2.047 Å) bond 
lengths are shorter than the Zn−N (2.155 Å). The average of dihedral angles between phenyl 
groups and chelate ring plane and also the C−C−C bond angle of β-diketone unit in 3opt are 
13.12 and 124.48° which are lower than those of complex 3. The dihedral angle between two 
pyridine rings of the 4,4'-bipyridine ligand is 0.00°, confirming that the planarity of this 
ligand in 3
opt
 as observed in 3.  
3.4 Docking studies 
For predicting and comparison the biological activates of the complex 3
2
 and its ligands (4,4'-
bipyridine and DPPD), interactions of these compounds with nine macromolecule receptors 
using Gold [63] docking software were studied. The Gold docking results are reported in 
terms of the values of fitness which means the higher the fitness the better the docked 
interaction of the compounds [53]. The results of the docking presented in this work is the 
best binding results out of the favorably ten predicted by Gold. 
                                                             
2 The compounds containing cadmium atom are not good choice for biological active compounds. 
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The general features from the Gold docking prediction (Table 4) show that all studied 
structures can be consider as biologically active compounds(Figures S9 and S10, S11 
Supplementary). The best predicted targets for the 4,4'-bipyridine and DPPD ligands is 
HDAC7 and TrxR, respectively, while for the studied complex 3 is TS. The GOLDScore 
fitness values of the complex 3 revealed that this complex can interact selectively with three 
biomacromolecules of RNR, TrxR and TS among the nine biomacromolecules. Also complex 
3 can interacted with the mentioned proteins better than the free ligands of 4,4'-bipyridine and 
DPPD. In other cases (other biomacromolecules than RNR, TrxR and TS) two free ligands 
are biologically active while after coordination to zinc they become inactive. A fitness value 
comparison between 4,4'-bipyridine and DPPD could allow to conclude that the DPPD has 
better binding ability toward proteins than the 4,4'-bipyridine.  
4. Conclusion  
Compounds of {(μ-OAc)(DPPD)Cd(μ-PYZ)Cd(DPPD)(μ-OAc)}n (1); HDPPD: 1,3-
diphenylpropane-1,3-dione, {Cd(μ-4,4'-Bipy)(DPPD)2}n (2), [(DPPD)2Zn(μ-4,4'-
Bipy)Zn(DPPD)2] (3), {Cd(μ-DPP)(DPPD)2}n (4); DPP: 1,3-di(pyridin-4-yl)propane and (Z)-
3-hydroxy-1,3-bis(4-methoxyphenyl)prop-2-en-1-one (Z-HMPP) were prepared; their 
spectral (IR, 
1
H NMR) and structural (single crystal X-ray diffraction) properties were 
investigated. Among these structures, the cadmium complexes 1, 2 and 4 have 1D polymeric 
structure with octahedral geometry containing N-donor ligands as linkers (in 1, there are two 
types of linker ligands, N-donor and O-donor). The complex 3 has binuclear structure and 
distorted square-pyramidal geometry at the zinc atom. Among the different coordination 
modes of the acetate ligand which is coordinated to the cadmium atom, the “(O,O)” mode is 
the most observed ones (54%). In all complexes, the bond angle of the β-diketone moiety and 
dihedral angles between phenyl groups with the mean plan through the chelate ring of this 
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moiety is increased with respect to the free ligand. In addition to the hydrogen bonds in the 
crystal network of the complexes, there are π–π stacking interactions between aromatic rings, 
showing the high ability of these molecules to interact with neighboring units and making 
them good choice to docking studies. The docking studies on the 4,4'-bipyridine, DPPD and 
complex 3 revealed that the these compounds might be biologically active by interacting with 
the nine biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, 
TS and Top II). The best predicted targets for the 4,4'-bipyridine, DPPD and complex 3 is 
HDAC7, TrxR and TS, respectively. Also 3 can interact selectively with three 
biomacromolecules of RNR, TrxR and TS. Based on the calculated fitness values of titled 
compounds, we suggest that studying anticancer activities of these compounds could be 
interesting. The PSS
5
 parameter for three complexes 1, 2 and 4 were calculated to be −2274, 
−2118 and −2000, confirming that by growing the chain of complex 1 the thermodynamic 
stability of it is increased higher than the others. The NBO analysis of the optimized complex 
3 revealed that the hydrogen and carbon atoms of two coordinated ligands act as electron 
donor and decrease the charge of the zinc atom.  
Appendix A. Supplementary data  
CCDC 1822845, 1822846, 1822849, 1822848 and 1822847 respectively for complexes 1–4 
and Z-HMPP contain the supplementary crystallographic data for this paper. These data can 
be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the 
Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: 
(+44) 1223-336-033; or e-mail: deposit@ccdc.cam.ac.uk. 
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Table 1. Crystal data and structure refinement for complexes of 1‒4 and Z-HMPP. 
 Z-HMPP Complex 1 Complex 2 Complex 3 Complex 4 
Empirical 
formula 
C17H16O4  C19H16CdNO4 C40H30CdN2O4 C70H52N2O8Zn2 C43H36CdN2O4 
Formula weight, 
g mol−1  
284.30 434.73 715.06 1179.87 757.14 
Crystal size, mm3 0.78 × 0.26 × 
0.14 
0.35 × 0.18 × 
0.03 
0.69 × 0.37 × 0.08 0.66 × 0.12 × 0.05 0.40 × 0.35 × 0.16 
Temperature, K  296 296 296 296 296 
Crystal system monoclinic triclinic Orthorhombic monoclinic monoclinic 
Space group P21/n P  Aba2 P21/c C2/c 
Unit cell 
dimensions (Å, °) 
     
a 4.1858(6) 6.5640(19) 10.9938(9) 10.8018(14) 13.1149(11) 
b 10.2691(16) 9.733(3) 25.63a5(3) 28.923(4) 30.534(3) 
c 32.589(5) 15.095(4) 11.8497(10) 18.183(2) 10.8920(9) 
α  94.274(6)    
β 90.758(3) 102.239  93.739(2) 125.236(1) 
γ  109.674(4)    
Volume, Å3 1400.7(4) 876.2(4) 3339.5(5) 5668.6(13) 3562.5(5) 
Z 4 2 4 4 4 
Calculated 
density, g cm−3 
1.348 1.648 1.422 1.383 1.412 
Absorption 
coefficient, mm−1 
0.10 1.27 0.70 0.91 0.66 
F(000), e 600 434 1456 2440 1552 
2θ range for data 
collection (°) 
4.6–44.8 5.0–50.8 4.8–58.2 4.4–33.6 5.4–49.4 
h, k, l ranges −5 ≤ h ≤ 5, −13 
≤ k ≤ 13, −44 ≤ 
l ≤ 44 
−8 ≤ h ≤ 7, −11 ≤ 
k ≤ 11, −18 ≤ l ≤ 
18 
−14 ≤ h ≤ 15, −35 
≤ k ≤ 35, −16 ≤ l ≤ 
16 
−13 ≤ h ≤ 13, −36 
≤ k ≤ 36, −23 ≤ l ≤ 
23 
−17 ≤ h ≤ 17, −41 
≤ k ≤ 41, −14 ≤ l ≤ 
14 
Reflections 
collected / 
independent / Rint 
28663 / 3717 / 
0.036 
3296 / 3296 /  33979 / 4496 / 
0.034 
117745 / 12379 / 
0.142 
42213 / 4791 / 
0.031 
Data / ref. 
parameters 
3717 / 196 3296 / 229 4496 / 215 12379 / 739 4791 / 252 
Goodness-of-fit 
on F2 
1.04 1.11 1.05 1.00 1.03 
Final R indexes 
[I>=2σ (I)] 
R1 = 0.047, 
wR2 = 0.127 
R1 = 0.040, wR2 = 
0.092 
R1 = 0.027, wR2 = 
0.063 
R1 = 0.054, wR2 = 
0.094 
R1 = 0.050, wR2 = 
0.141 
Final R indexes 
[all data] 
R1 = 0.087, 
wR2 = 0.150 
R1 = 0.045, wR2 = 
0.095 
R1 = 0.037, wR2 =  
0.069 
R1 = 0.148, wR2 =  
0.131 
R1 = 0.063, wR2 =  
0.154 
Largest diff. peak 
/ hole, e Å–3                    
0.12 / −0.14 1.21 / –0.56 0.41 / –0.26 0.29 / –0.23 0.62 / –0.66 
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Table 2. Selected bond length (Å) and angles (°) for complexes 1–4 and Z-HMPP with standard deviations in parentheses. 
 Z-HMPP  1  2  3  4    
D
is
ta
n
ce
s 
C7−O1 1.287(2) Cd1−O1 2.241(5) Cd1−O1 2.241 Zn1A−O1A 2.002(2) Cd1−O1 2.241   
C9−O2 1.295(2) Cd1−O2 2.193(4) Cd1−O2 2.240 Zn1A −O2A 2.036(3) Cd1−O2 2.240   
C3−O3 1.352(2) Cd1−O3 2.264(4) Cd1−N1 2.35 Zn1A −O3A 2.012(3) Cd1−N1 2.370   
C13−O4 1.361(2) Cd1−O4 2.569(5) Cd1−N2 2.43 Zn1A –O4A 1.972(3)     
C6−7 1.465(2) Cd1−O4 2.310(5)   Zn1A –N1A 2.058(3)     
C9−C10 1.463(2) Cd1−N1 2.302(5)         
A
n
g
le
s 
C4− C3−O3 116.2(1) O1− Cd1−O2 82.5(2) O1− Cd1−O2 83.2 O1A− Zn1A−O2A 87.2(1) O1−Cd1−O2 81.1   
C6− C7−O1 116.5(1) O2− Cd1−O3 141.5(2) O2− Cd1−N2 82.1 O2A− Zn1A−O3A 165.5(1) O2−Cd1−O2 95.9   
C8− C9−O2 119.4(1) O3− Cd1− O4 52.8(2) N2− Cd1− N1 180.0 O3A− Zn1A–O4A 89.4(1) O1−Cd1−N1 96.3   
C12− C13−O4 124.9(2) O4− Cd1− O4 73.5(2) N1− Cd1− O1 87.3 O4A− Zn1A−N1A 100.9(1) N1−Cd1−N1 94.2   
  O4− Cd1−N1 89.5(2)   N1A− Zn1A−O2A 94.9(1)     
  N1− Cd1−O1 88.3(2)         
 
 
 
 
 
 
 
 
 
 
 
 
 
  
27 
 
 
Table 3. Differences (∆) of the C−C and C−O bond lengths and central C−C−C bond angle of the β-diketone 
unit and dihedral angles average between phenyl groups with the mean plan through the chelate ring of the 
coordinated DPPD in the complexes 1−4 and HDPPD. 
 ∆ (C−C) ∆ (C−O) C−C−C Dihedral Angle 
HDPPD 0.027 0.025 120.42° 10.86° 
1 0.005 0.008 127.20 39.07 
2 0.018 0.000 127.93 41.85° 
3 0.005 0.006 126.00 14.57° 
4 0.000 0.007 127.03 19.89 
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Table 4. The calculated fitness values for the complex 3, 4,4'-bipyridine and DPPD.  
Top 
II 
TS TrxR RNR rHA HDAC7 
DNA-
Gyrase 
CatB 
BRAF-
Kinase 
 
32.44 32.93 36.76 32.75 33.95 38.16 36.27 24.02 33.85 4,4'-Bipyridine 
41.77 39.88 45.58 36.98 43.64 45.11 39.68 28.70 42.73 DPPD 
0.00 81.66 63.56 79.60 −185.66 0.00 0.00 0.00 0.00 Complex 3 
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Figure Captions 
Scheme 1. Structures of the 1,3-diphenylpropane-1,3-dione (HDPPD), pyrazine (PYZ), 4,4'-
bipyridine (4,4'-Bipy) and 1,3-di(pyridin-4-yl)propane (DPP) ligands. 
 
Figure 1. ORTEP diagram of the excerpt from coordination polymer structure of 1. The 
ellipsoids are drawn at the 35% probability level. 
Figure 2. Pie chart, the percentage of different coordination modes of the acetato ligand 
among the complexes of cadmium. 
Figure 3. ORTEP diagram of the excerpt from coordination polymer structure of 2. The 
ellipsoids are drawn at the 35% probability level.     
Figure 4. ORTEP diagram of the molecular structure of 3. The ellipsoids are drawn at the 
25% probability level.     
Figure 5. ORTEP diagram of the excerpt from coordination polymer structure of 4. The 
ellipsoids are drawn at the 35% probability level.   
Figure 6. ORTEP diagram of the molecular structure of Z-HMPP. The ellipsoids are drawn at 
the 35% probability level.   
 
Figure 7. Variation diagram of total intermolecular interactions energy (E) for complex 3 and 
Z-HMPP with increasing the number of surrounding molecules. 
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Figure 8. Variation of the energy level with growing the polymeric chain in the solid phase of 
complexes 1, 2 and 4. 
Figure 9. Docking study results, showing t complex 3 TS protein. 
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HDPPD PYZ 
  
  
DPP 4,4'-Bipy 
Scheme 1. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
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Figure 6. 
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Figure 7. 
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Figure 8. 
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Figure 9. 
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Five compounds, {(μ-acetato)(DPPD)Cd(μ-pyrazine)Cd(DPPD)(μ-acetato)}n (1); 
HDPPD: 1,3-diphenylpropane-1,3-dione, {Cd(μ-4,4'-bipyridine)(DPPD)2}n (2), 
[(DPPD)2Zn(μ-4,4'-bipyridine)Zn(DPPD)2] (3), {Cd(μ-DPP)(DPPD)2}n (4); DPP: 1,3-
di(pyridin-4-yl)propane and (Z)-3-hydroxy-1,3-bis(4-methoxyphenyl)prop-2-en-1-one (Z-
HMPP) were prepared and their spectral and structural properties were investigated. 
Experimental data are compared with the CSD database and theoretical results. Biological 
activities are investigated by docking studies.  
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